Search

Your search keyword '"Poggio, F"' showing total 402 results

Search Constraints

Start Over You searched for: Author "Poggio, F" Remove constraint Author: "Poggio, F"
402 results on '"Poggio, F"'

Search Results

151. Trigger detectors for the ALICE muon spectrometer

152. Thermal neutron detection with Resistive Plate Chambers via the 10B(n,α)7Li reaction

153. Test beam results on the Proton Zero Degree Calorimeter for the ALICE experiment

154. Performance of the Zero Degree Calorimeters for the ALICE experiment

155. RPC AS THERMAL NEUTRON DETECTOR FOR HUMANITARIAN DE-MINING

156. Detecting landmines by neutron induced reactions: the DIAMINE sensor

160. Charged-particle multiplicity measurement in proton–proton collisions at $\sqrt{s}=0.9$ and 2.36 TeV with ALICE at LHC

164. ALICE electromagnetic calorimeter technical design report

168. First proton--proton collisions at the LHC as observed with the ALICE detector: measurement of the charged particle pseudorapidity density at $\ sqrt(s)$= 900 GeV

169. Alignment of the ALICE Inner Tracking System with cosmic-ray tracks

170. Transverse momentum spectra of charged particles in proton-proton collisions at $\sqrt{s} = 900$~GeV with ALICE at the LHC

171. Charged-particle multiplicity measurement in proton-proton collisions at sqrt(s) = 7 TeV with ALICE at LHC

172. Charged-particle multiplicity measurement in proton-proton collisions at sqrt(s) = 0.9 and 2.36 TeV with ALICE at LHC

173. ALICE Electromagnetic Calorimeter Technical Design Report

175. R and D on RPC for the muon trigger system for the ALICE experiment in view of p-p data taking

176. Dependence of bakelite resistivity on temperature and humidity

177. Ageing test of RPC for the muon trigger system for the ALICE experiment

178. The proton zero degree calorimeter for the ALICE experiment

181. Ovarian suppression using luteinizing hormonereleasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

185. 124 (PB-124) Poster - Adjuvant endocrine therapy choices in premenopausal patients with estrogen receptor-positive early breast cancer: insights from the GIM23-POSTER study.

187. 90O The role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial.

188. Virginal

189. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial

190. Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)

191. Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

192. Thermal neutron detection with Resistive Plate Chambers via the 10B(n,α)7Li reaction

193. 95TiP Gruppo Italiano Mammella (GIM) 10 – CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR+) early breast cancer (EBC)

194. 186P - Efficacy of dose-dense (DD) adjuvant chemotherapy (CT) in hormone receptor positive/HER2-negative early breast cancer (BC) patients (pts) according to immunohistochemically (IHC) defined luminal subtypes: An exploratory analysis of the GIM2 trial.

196. The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer.

197. Controversies on chemotherapy for early HR+/HER2- breast cancer: the role of anthracyclines and dose intensification.

198. [Clinical management of a patient with non-triple-negative breast cancer who converts to a triple-negative subtype at recurrence.]

199. Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study.

200. Investigating the interplay between segregation and integration in developing cortical assemblies.

Catalog

Books, media, physical & digital resources